Preview: what to expect from MSVirtual2020?

neurodiem-image

MSVirtual2020 (11-13 September) will be the 8th joint ACTRIMS-ECTRIMS meeting, and the first with a fully virtual program. The sessions this year are organized into parallel, thematically focused tracks.

The Clinical Track highlights emerging trends in the customization of MS clinical trials and disease modifying therapies, based on demographics, and disease stage and activity. Updates will be given on clinical trials in progressive MS, and on escalation versus aggressive treatment approaches in relapsing MS. In addition, there will be news of exciting advances in the use of neurorehabilitation and neuroprosthetics/robotics to alleviate symptoms and enhance function.

The Pathogenesis Track explores our growing understanding of the heterogeneity and sub-specialization of innate and adaptive leukocytes implicated in the pathogenesis and regulation of MS. New discoveries about two-way communication between the CNS and the gut/microbiome during MS, and about the neuronal and glial response to neuroinflammation, will be shared.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.